|
1
|
Zimonjic DB, Keck CL, Thorgeirsson SS and
Popescu NC: Novel recurrent genetic imbalances in human
hepatocellular carcinoma cell lines identified by comparative
genomic hybridization. Hepatology. 29:1208–1214. 1999. View Article : Google Scholar
|
|
2
|
Nowak AK, Chow PK and Findlay M: Systemic
therapy for advanced hepatocellular carcinoma: a review. Eur J
Cancer. 40:1474–1484. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ma CY, Ji WT, Chueh FS, Yang JS, Chen PY,
Yu CC and Chung JG: Butein inhibits the migration and invasion of
SK-HEP-1 human hepatocarcinoma cells through suppressing the ERK,
JNK, p38, and uPA signaling multiple pathways. J Agric Food Chem.
59:9032–9038. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lu CC, Yang JS, Chiang JH, Hour MJ, Lin
KL, Lin JJ, Huang WW, Tsuzuki M, Lee TH and Chung JG: Novel
quinazolinone MJ-29 triggers endoplasmic reticulum stress and
intrinsic apoptosis in murine leukemia WEHI-3 cells and inhibits
leukemic mice. PLoS One. 7:e368312012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yang JS, Hour MJ, Huang WW, Lin KL, Kuo SC
and Chung JG: MJ-29 inhibits tubulin polymerization, induces
mitotic arrest, and triggers apoptosis via cyclin-dependent kinase
1-mediated Bcl-2 phosphorylation in human leukemia U937 cells. J
Pharmacol Exp Ther. 334:477–488. 2010. View Article : Google Scholar
|
|
6
|
Kelloff GJ, Crowell JA, Steele VE, et al:
Progress in cancer chemoprevention: development of diet-derived
chemopreventive agents. J Nutr. 130:467S–471S. 2000.PubMed/NCBI
|
|
7
|
Lavrik IN, Golks A and Krammer PH:
Caspases: pharmacological manipulation of cell death. J Clin
Invest. 115:2665–2672. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wen YF, Lee KH, Huang PT, Chen MH, Shin
WC, Huang LJ, Hsu MH, Chen CJ and Kuo SC: Cell differentiation
enhancement by hydrophilic derivatives of
4,8-dihydrobenzo[1,2-b:5,4-b’]dithiophene-4,8-diones in HL-60
leukemia cells. Bioorg Med Chem Lett. 17:2908–2912. 2007.PubMed/NCBI
|
|
9
|
Wen YF, Yang JS, Kuo SC, Hwang CS, Chung
JG, Wu HC, Huang WW, Jhan JH, Lin CM and Chen HJ: Investigation of
anti-leukemia molecular mechanism of ITR-284, a carboxamide analog,
in leukemia cells and its effects in WEHI-3 leukemia mice. Biochem
Pharmacol. 79:389–398. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ip SW, Wei HC, Lin JP, Kuo HM, Liu KC, Hsu
SC, Yang JS, Mei-Dueyang, Chiu TH, Han SM and Chung JG: Bee venom
induced cell cycle arrest and apoptosis in human cervical
epidermoid carcinoma Ca Ski cells. Anticancer Res. 28:833–842.
2008.PubMed/NCBI
|
|
11
|
Lin ML, Chen SS, Lu YC, Liang RY, Ho YT,
Yang CY and Chung JG: Rhein induces apoptosis through induction of
endoplasmic reticulum stress and Ca2+-dependent
mitochondrial death pathway in human nasopharyngeal carcinoma
cells. Anticancer Res. 27:3313–3322. 2007.PubMed/NCBI
|
|
12
|
Yang JS, Chen GW, Hsia TC, Ho HC, Ho CC,
Lin MW, Lin SS, Yeh RD, Ip SW, Lu HF and Chung JG: Diallyl
disulfide induces apoptosis in human colon cancer cell line (COLO
205) through the induction of reactive oxygen species, endoplasmic
reticulum stress, caspases casade and mitochondrial-dependent
pathways. Food Chem Toxicol. 47:171–179. 2009. View Article : Google Scholar
|
|
13
|
Yang JS, Hour MJ, Kuo SC, Huang LJ and Lee
MR: Selective induction of G2/M arrest and apoptosis in HL-60 by a
potent anticancer agent, HMJ-38. Anticancer Res. 24:1769–1778.
2004.PubMed/NCBI
|
|
14
|
Packard BZ, Toptygin DD, Komoriya A and
Brand L: Profluorescent protease substrates: intramolecular dimers
described by the exciton model. Proc Natl Acad Sci USA.
93:11640–11645. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lukka PB, Kestell P, Paxton JW and Baguley
BC: Development and validation of a liquid chromatography-mass
spectrometry (LC-MS) assay for the determination of the anti-cancer
agent
N-[2-(dimethylamino)ethyl]-2,6-dimethyl-1-oxo-1,2-dihydrobenzo[b]-1,6-naph
thyridine-4-carboxamide (SN 28049). J Chromatogr B Analyt Technol
Biomed Life Sci. 875:368–372. 2008.PubMed/NCBI
|
|
16
|
Feng W, Satyanarayana M, Tsai YC, Liu AA,
Liu LF and LaVoie EJ: 11-Substituted
2,3-dimethoxy-8,9-methylenedioxybenzo[i]phenanthridine derivatives
as novel topoisomerase I-targeting agents. Bioorg Med Chem.
16:8598–8606. 2008.PubMed/NCBI
|
|
17
|
Creighton-Gutteridge M, Cardellina JH II,
Stephen AG, Rapisarda A, Uranchimeg B, Hite K, Denny WA, Shoemaker
RH and Melillo G: Cell type-specific, topoisomerase II-dependent
inhibition of hypoxia-inducible factor-1alpha protein accumulation
by NSC 644221. Clin Cancer Res. 13:1010–1018. 2007. View Article : Google Scholar : PubMed/NCBI
|
